2024 CSCO Breast Cancer guidelines revolutionize treatment approaches in China

Breast cancer remains a major global health challenge, with treatment strategies varying widely across regions. The continuous development of new therapies, combined with the pressing need to personalize treatments for diverse patient populations, underscores the importance of evidence-based guidelines that blend global innovations with local healthcare needs. This challenge calls for guidelines that not only reflect international advancements but also take into account the clinical realities and accessibility within specific regions, particularly in China. The 2024 Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines, released (DOI: 10.20892/j.issn.2095-3941.2024.0374) in Cancer Biology & Medicine, represent a pioneering effort by a…